Low dose Galcanezumab for treating trigeminal autonomic cephalalgias: clinical observation from Colombia and Mexico on behalf of ASOLAC. Headache Med [Internet]. 2025 Mar. 30 [cited 2026 Jan. 22];16(1):65-70. Available from: https://headachemedicine.com.br/hm/article/view/1340